Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Hammarsten

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|November 9, 2001
DNA-dependent protein kinase catalytic subunit. Structural requirements for kinase activation by DNA endsSusanne Mårtensson, Ola Hammarsten
Lakartidningen|January 3, 2018
[Suspected cardiac chest pain in the emergency department]Christian Bjurman, Ola Hammarsten, Martin Holzmann
European Journal of Heart Failure|February 17, 2010
Red cell distribution width in chronic heart failure: a new independent marker for prognosis?Ola Hammarsten, Stefan Jacobsson, Michael Fu
Lakartidningen|July 30, 2014
[Evaluation of patients with chest pain: Can we settle with measurement of troponin only on arrival?]Kai Eggers, Ola Hammarsten, Bertil Lindahl
Clinical Chemistry and Laboratory Medicine|January 10, 2022
Which method to detect macrotroponin?Leo Lam, Ola Hammarsten, Campbell Kyle
Lakartidningen|May 4, 2026
[Persistent very high levels of P-cobalamin caused by formation of immune complexes, macro-B12]Leif Wiklund, Mohammed Hadi, Ola Hammarsten
Toxicology and Applied Pharmacology|March 8, 2014
Repeated Nrf2 stimulation using sulforaphane protects fibroblasts from ionizing radiationSherin T Mathew, Petra Bergström, Ola Hammarsten
Clinical Chemistry and Laboratory Medicine|November 25, 2022
Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implicationsKai M Eggers, Ola Hammarsten, Bertil Lindahl
Clinical Biochemistry|March 8, 2023
Methods for analyzing positive cardiac troponin assay interferenceOla Hammarsten, Charlotte Becker, Anna E Engberg
Plos One|June 12, 2009
Numerical analysis of etoposide induced DNA breaksAida Muslimović, Susanne Nyström, Yue Gao, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|November 9, 2001
DNA-dependent protein kinase catalytic subunit. Structural requirements for kinase activation by DNA endsSusanne Mårtensson, Ola Hammarsten
Lakartidningen|January 3, 2018
[Suspected cardiac chest pain in the emergency department]Christian Bjurman, Ola Hammarsten, Martin Holzmann
European Journal of Heart Failure|February 17, 2010
Red cell distribution width in chronic heart failure: a new independent marker for prognosis?Ola Hammarsten, Stefan Jacobsson, Michael Fu
Lakartidningen|July 30, 2014
[Evaluation of patients with chest pain: Can we settle with measurement of troponin only on arrival?]Kai Eggers, Ola Hammarsten, Bertil Lindahl
Clinical Chemistry and Laboratory Medicine|January 10, 2022
Which method to detect macrotroponin?Leo Lam, Ola Hammarsten, Campbell Kyle
Lakartidningen|May 4, 2026
[Persistent very high levels of P-cobalamin caused by formation of immune complexes, macro-B12]Leif Wiklund, Mohammed Hadi, Ola Hammarsten
Toxicology and Applied Pharmacology|March 8, 2014
Repeated Nrf2 stimulation using sulforaphane protects fibroblasts from ionizing radiationSherin T Mathew, Petra Bergström, Ola Hammarsten
Clinical Chemistry and Laboratory Medicine|November 25, 2022
Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implicationsKai M Eggers, Ola Hammarsten, Bertil Lindahl
Clinical Biochemistry|March 8, 2023
Methods for analyzing positive cardiac troponin assay interferenceOla Hammarsten, Charlotte Becker, Anna E Engberg
Plos One|June 12, 2009
Numerical analysis of etoposide induced DNA breaksAida Muslimović, Susanne Nyström, Yue Gao, et al.
Pageof 10